ProterixBio Sponsoring and Speaking at the Powering Precision Health Summit 2016
September 26, 2016 – ProterixBio, Inc. has been named an official sponsor of the Powering Precision Health Summit 2016, to be held September 26th at the Boston Marriott Cambridge. The first annual summit brings together the world’s foremost physicians, scientists, health and technology innovators to present the latest technologies that are advancing personalized medicine. The… Read more »
ProterixBio Joins the Industrial Advisory Boards of the COPD Foundation and the SPIROMICS Consortium
Billerica, MA, September 13, 2016 – ProterixBio, Inc. today announced that it has joined the Industrial Advisory boards of the COPD (chronic obstructive pulmonary disease) Foundation and the SPIROMICS Consortium. Joining both advisory boards reflects ProterixBio’s commitment to develop novel clinical applications including diagnostics products and disease management tools for pulmonary diseases. ProterixBio is developing… Read more »
ProterixBio and the University of Zurich Receive Michael J. Fox Foundation Grant to Develop a Novel Assay for Alpha-synuclein Aggregates
Billerica, MA – ProterixBio, Inc. today announced the receipt of a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The grant funds a collaboration between ProterixBio and the University of Zurich in Switzerland focused on the development of a novel bioanalytical assay workflow that aims to measure small amounts of aberrant alpha-synuclein… Read more »